| Value | ₹2.85 Cr |
|---|
BSE filing, NSE: DDIL. Summary written from the filing by ALFA Finder's alert engine.
Deep Health AI India Ltd: key numbers
- Share price
- ₹1.60
- Market cap
- ₹23.06 Cr
- Revenue (annual)
- ₹4.25 Cr
- Net profit (annual)
- ₹1.13 Cr
- P/E (TTM)
- -21.4×Sector 49.0×
- Promoter holding
- 0.03%+0.00% QoQ
- FII holding
- 0.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Deep Health AI India Ltd
All →Deep Health AI India Other Announcement
Deep Health AI India Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Deep Health AI India Acquisition Worth ₹10.35 Cr
Deep Health AI India Limited acquired debt and underlying security from Kshitij Polyline Limited for ₹10.35 Crore. The assignment secures rights in Sparion Infrastructure Private Limited.
- Value
- ₹10.35 Cr
Deep Health AI India Management Change
Deep Health AI India Limited appointed Virendra Choubisa as Non-Executive Director and M/s Vimal C Surana as statutory auditor, replacing outgoing auditor M/s VRSK & Co. LLP.
Deep Health AI India Annual General Meeting
Deep Health AI India Limited successfully concluded its 32nd Annual General Meeting on September 30, 2026, where all proposed resolutions were passed by the members.
Deep Health AI India Management Change
Deep Health AI India Limited has announced the resignation of Mr. Rajesh Nandkishore Pherwani as a Non-Executive Independent Director, effective September 11, 2026.
Deep Health AI India Other Announcement
Deep Health AI India sent a Reg 36(1)(b) letter to shareholders with unregistered emails, providing the Annual Report FY25-26 weblink and AGM e-voting details. No financial or business substance is disclosed.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr